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Non-protein amino acids are a group of small molecules with structural similarities to the 
canonical amino acids used in protein synthesis. Many of these molecules are produced by 
plants, animals, bacteria, and fungi, and are ubiquitous within our environment.  A number of 
non-protein amino acids have been linked to human pathologies, including a number of 
neurodegenerative diseases.  
β-methylamino-L-alanine (BMAA) is a cyanobacterial-derived non-protein amino acid that has 
been linked to the development of amyotrophic lateral sclerosis, as well as Parkinson’s disease 
and dementia. Following its discovery in the 1960s, BMAA has been shown to be produced by a 
number cyanobacteria, and more recently other phytoplankton species including diatoms and 
dinoflagellates. BMAA is found globally in freshwater, saltwater, and terrestrial environments. 
While BMAA has been identified in samples sourced from a huge variety of global ecosystems, 
its presence in Australian waterways has remained largely unexplored. For this study, sixteen 
mixed population algal surface bloom samples were collected from a number of sites in urban 
and rural New South Wales. The presence of BMAA, and its isomers L-2,4-Diaminobutyric acid 
(2,4-DAB) and N-(2-Aminoethyl) glycine (AEG) was determined using reverse phase liquid 
chromatography – tandem mass spectrometry. Ten of the samples were found to contain BMAA, 
while 2,4-DAB was found in all sixteen. The presence of these suspected toxins in urban areas, 
as well as in waterways critical for agriculture, suggests Australians may be exposed to BMAA 
and 2,4-DAB regularly.  
The ability of BMAA to associate strongly with proteins has been well reported. To investigate 
this relationship, radio labelled BMAA was incubated with both human neuroblastoma cells and 
Escherichia coli. Protein-bound BMAA increased in a linear fashion over time in neuroblastoma 





BMAA differently. Protein bound BMAA was only observed in live cells and not in protein lysates 
indicating that some form of biological processing is required for protein binding to occur. 
Protein bound BMAA was also found to distribute across fractionated cell proteins in the same 
manner as 3H leucine, suggesting both share similar binding properties.  
The potential for synergistic toxicity between BMAA and its structural isomers, 2,4-DAB and AEG, 
was also explored. Cell viability was significantly reduced in cells exposed to BMAA or 2,4-DAB 
in concentrations as low as 250 μM, and similar toxicity was only observed in AEG treated cells 
at concentrations of 1000 μM or higher. Cells exposed to BMAA, or combinations of BMAA and 
other isomers, resulted in increased expression of a number of markers of endoplasmic 
reticulum (ER) mediated proteotoxic stress, a phenomenon that was not observed in cells 
exposed to 2,4-DAB or AEG on their own. Significant increases in caspase 3 and cathepsin activity 
were only observed in cells incubated with a combination of BMAA and 2,4-DAB, suggesting that 
while 2,4-DAB does not share the same mechanism of toxicity as BMAA, it may contribute to its 
cytotoxicity.  
We observed that neuroblastoma cells exposed to BMAA produced a number of markers of 
proteotoxic stress, including increases in caspase 3 and cathepsin activity as well as increased 
expression of the ER stress marker CCAAT/-enhancer-binding protein homologous protein 
(CHOP). Co-incubation with low concentrations of L-serine resulted in complete inhibition of this 
toxicity, supporting the hypothesis that BMAA is misincorporated into proteins in place of L-
serine or that L-serine can counteract the cytotoxicity associated with BMAA through other 
mechanisms. These results also suggest that the effects of BMAA exposure may be mitigated 
through the use of L-serine, providing a possible pharmacological intervention for 
neurodegenerative disease sufferers affected by BMAA exposure.  
The sporadic nature of a number of neurodegenerative diseases strongly indicates the presence 





amino acids are neurotoxic and may play a role as an environmental factor in the onset of 
disease. The formation of aberrant protein structures is a hallmark of neurodegeneration; the 
affinity of BMAA to bind to proteins, as well as its ability to induce ER-stress, is a strong indication 
that BMAA may be misincorporated into proteins. This is supported by the evidence that BMAA 
toxicity is mitigated through co-exposure to L-serine. Moving forward, robust and ongoing 
monitoring of these toxins in rural and urban waterways is critical to our understanding of the 
risk of human exposure, as well as the identification of potential exposure routes.
